• Ethan Dmitrovsky with symposium attendees.

    Cancer Biologists Get Expert Perspective on Research Potential of Imaging Technologies

    The scientists convened at Hood College June 21-23. 

    Read More View All
  • Tumor tissue will undergo testing for changes in more than 160 genes. If a patient's tumor has a genetic change that matches one targeted by a drug used in the trial, the patient may be eligible to join the treatment arm targeting that genetic change.

    Patient Eligibility for Pediatric Precision Medicine Trial Doubles Estimates

    The trial launched in 2017 with significant support from the Frederick National Laboratory.

    Read More View All
  • NHP Models- Medicine, Simian Immunodeficiency Virus (SIV), Simian/Human Immunodeficiency Virus (SHIV), FNL SHIVs, FNL Barcoded SIV, Analysis, Study Design

    Frederick National Laboratory Develops New Tools for HIV Research

    FNL partnered with NIAID and other collaborators on the project. 

    Read More View All
  • Stock image of blood in a test tube.

    FNL Partners with Illumina for Clinical Validation of Liquid Biopsies

    The work was presented at the ASCO Annual Meeting.

    Read More View All
  • Illustration of nanotechnology-based products, leukocytes, platelets, and complement.

    New Technical Service Helps Identify Infusion Reaction Risk

    The service is offered by the Nanotechnology Characterization Laboratory.

    Read More View All
Who We Are Discovery, innovation, and success in the biomedical sciences. Learn More

The Frederick National Laboratory is dedicated to improving human health through discovery and innovation in the biomedical sciences, focusing on cancer, AIDS, and emerging infectious diseases.